Loading...

We've got a brand new version of Simply Wall St! Try it out

Challenger

DB:GK9
Snowflake Description

6 star dividend payer and undervalued.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
GK9
DB
A$4B
Market Cap
  1. Home
  2. DE
  3. Diversified Financials
Company description

Challenger Limited is a publicly owned investment manager. The last earnings update was 62 days ago. More info.


Add to Portfolio Compare Print
  • Challenger is a fund or ETF! Currently our data availability for these is poor, we only recommend using them as part of a portfolio.
GK9 Share Price and Events
7 Day Returns
-1%
DB:GK9
5%
DE Diversified Financial
2.8%
DE Market
1 Year Returns
-35%
DB:GK9
1.4%
DE Diversified Financial
3%
DE Market
GK9 Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Challenger (GK9) -1% -5.8% 0.5% -35% -39.4% -6.9%
DE Diversified Financial 5% 7.8% -5% 1.4% 75.8% 333.7%
DE Market 2.8% 0.2% 1.3% 3% 8% 23.6%
1 Year Return vs Industry and Market
  • GK9 underperformed the Diversified Financial industry which returned 1.4% over the past year.
  • GK9 underperformed the Market in Germany which returned 3% over the past year.
Price Volatility
GK9
Industry
5yr Volatility vs Market

Value

 Is Challenger undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Challenger to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Challenger.

DB:GK9 Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model Excess Returns Model
Stable EPS Weighted future Return on Equity estimates from 10 analysts.
= Stable Book Value * Return on Equity
= A$6.14 * 10.8%
A$0.67
Book Value of Equity per Share Weighted future Book Value estimates from 6 analysts. A$6.14
Discount Rate (Cost of Equity) See below 5.3%
Perpetual Growth Rate 10-Year DE Government Bond Rate 0.2%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for DB:GK9
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year DE Govt Bond Rate 0.2%
Equity Risk Premium S&P Global 6%
Diversified Financial Unlevered Beta Simply Wall St/ S&P Global 0.72
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.72 (1 + (1- 30%) (177.84%))
0.859
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.86
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 0.23% + (0.859 * 5.96%)
5.35%

Discounted Cash Flow Calculation for DB:GK9 using Excess Returns Model Model

The calculations below outline how an intrinsic value for Challenger is arrived at using the Excess Return Model. This approach is used for finance firms where free cash flow is difficult to estimate.

In the Excess Return Model the value of a firm can be written as the sum of capital invested currently in the firm and the present value of excess returns that the firm expects to make in the future.

The model is sensitive to the Return on Equity of the company versus the Cost of Equity, how these are calculated is detailed below the main calculation.

Note the calculations below are per share.

See our documentation to learn about this calculation.

DB:GK9 Value of Excess Returns
Calculation Result
Excess Returns = (Stable Return on equity – Cost of equity) (Book Value of Equity per share)
= (10.8% – 5.35%) * A$6.14)
A$0.34
Terminal Value of Excess Returns = Excess Returns / (Cost of Equity - Expected Growth Rate)
= A$0.34 / (5.35% - 0.23%)
A$6.58
Value of Equity = Book Value per share + Terminal Value of Excess Returns
= A$6.14 + A$6.58
A$12.72
DB:GK9 Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in DB:GK9 represents 0.60058x of ASX:CGF
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.60058x
Value per Share
(Listing Adjusted, EUR)
= Value per Share (AUD) x Listing Adjustment Factor
= A$ 12.72 x 0.60058
€7.64
Value per share (EUR) From above. €7.64
Current discount Discount to share price of €4.12
= -1 x (€4.12 - €7.64) / €7.64
46.1%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Challenger is available for.
Intrinsic value
46%
Share price is €4.12 vs Future cash flow value of €7.64
Current Discount Checks
For Challenger to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Challenger's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • Challenger's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Challenger's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Challenger's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
DB:GK9 PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-06-30) in AUD A$0.51
ASX:CGF Share Price ** ASX (2019-10-11) in AUD A$6.86
Germany Diversified Financial Industry PE Ratio Median Figure of 6 Publicly-Listed Diversified Financial Companies 27.82x
Germany Market PE Ratio Median Figure of 417 Publicly-Listed Companies 19.72x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Challenger.

DB:GK9 PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= ASX:CGF Share Price ÷ EPS (both in AUD)

= 6.86 ÷ 0.51

13.48x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Challenger is good value based on earnings compared to the DE Diversified Financial industry average.
  • Challenger is good value based on earnings compared to the Germany market.
Price based on expected Growth
Does Challenger's expected growth come at a high price?
Raw Data
DB:GK9 PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 13.48x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 11 Analysts
10%per year
Europe Diversified Financial Industry PEG Ratio Median Figure of 13 Publicly-Listed Diversified Financial Companies 1.81x
Germany Market PEG Ratio Median Figure of 265 Publicly-Listed Companies 1.39x

*Line of best fit is calculated by linear regression .

DB:GK9 PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 13.48x ÷ 10%

1.34x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Challenger is poor value based on expected growth next year.
Price based on value of assets
What value do investors place on Challenger's assets?
Raw Data
DB:GK9 PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-06-30) in AUD A$5.94
ASX:CGF Share Price * ASX (2019-10-11) in AUD A$6.86
Germany Diversified Financial Industry PB Ratio Median Figure of 9 Publicly-Listed Diversified Financial Companies 3.77x
Germany Market PB Ratio Median Figure of 598 Publicly-Listed Companies 1.74x
DB:GK9 PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= ASX:CGF Share Price ÷ Book Value per Share (both in AUD)

= 6.86 ÷ 5.94

1.15x

* Primary Listing of Challenger.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Challenger is good value based on assets compared to the DE Diversified Financial industry average.
X
Value checks
We assess Challenger's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Diversified Financial industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Diversified Financial industry average (and greater than 0)? (1 check)
  5. Challenger has a total score of 5/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Challenger expected to perform in the next 1 to 3 years based on estimates from 11 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
10%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Challenger expected to grow at an attractive rate?
  • Challenger's earnings growth is expected to exceed the low risk savings rate of 0.2%.
Growth vs Market Checks
  • Challenger's earnings growth is positive but not above the Germany market average.
  • Challenger's revenues are expected to decrease over the next 1-3 years, this is below the Germany market average.
Annual Growth Rates Comparison
Raw Data
DB:GK9 Future Growth Rates Data Sources
Data Point Source Value (per year)
DB:GK9 Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 11 Analysts 10%
DB:GK9 Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 11 Analysts -52.8%
Germany Diversified Financial Industry Earnings Growth Rate Market Cap Weighted Average 17.3%
Europe Diversified Financial Industry Revenue Growth Rate Market Cap Weighted Average 0.6%
Germany Market Earnings Growth Rate Market Cap Weighted Average 12.8%
Germany Market Revenue Growth Rate Market Cap Weighted Average 5%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
DB:GK9 Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 11 Analyst Estimates (S&P Global) See Below
All numbers in AUD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
DB:GK9 Future Estimates Data
Date (Data in AUD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2022-06-30 875 381 425 8
2021-06-30 852 361 387 11
2020-06-30 828 341 367 11
2019-10-13
DB:GK9 Past Financials Data
Date (Data in AUD Millions) Revenue Cash Flow Net Income *
2019-06-30 3,280 652 308
2019-03-31 2,955 1,159 221
2018-12-31 2,630 1,665 133
2018-09-30 2,748 1,821 228
2018-06-30 2,865 1,977 323
2018-03-31 2,997 1,801 357
2017-12-31 3,128 1,624 392
2017-09-30 3,035 1,611 395
2017-06-30 2,941 1,597 398
2017-03-31 2,490 1,676 346
2016-12-31 2,040 1,755 295
2016-09-30 2,039 1,519 311

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Challenger's earnings are expected to grow by 10% yearly, however this is not considered high growth (20% yearly).
  • Challenger's revenue is expected to decrease over the next 1-3 years, this is not considered high growth.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
DB:GK9 Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 11 Analyst Estimates (S&P Global) See Below

All data from Challenger Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:GK9 Future Estimates Data
Date (Data in AUD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2022-06-30 0.57 0.66 0.53 6.00
2021-06-30 0.57 0.66 0.47 9.00
2020-06-30 0.54 0.63 0.45 9.00
2019-10-13
DB:GK9 Past Financials Data
Date (Data in AUD Millions) EPS *
2019-06-30 0.51
2019-03-31 0.36
2018-12-31 0.22
2018-09-30 0.38
2018-06-30 0.54
2018-03-31 0.61
2017-12-31 0.68
2017-09-30 0.69
2017-06-30 0.71
2017-03-31 0.62
2016-12-31 0.52
2016-09-30 0.55

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Challenger is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess Challenger's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Germany market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Europe market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Challenger has a total score of 1/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Challenger performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Challenger's growth in the last year to its industry (Diversified Financial).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Challenger's year on year earnings growth rate was negative over the past 5 years and the most recent earnings are below average.
  • Challenger's 1-year earnings growth is negative, it can't be compared to the 5-year average.
  • Challenger's 1-year earnings growth is negative, it can't be compared to the Europe Diversified Financial industry average.
Earnings and Revenue History
Challenger's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Challenger Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:GK9 Past Revenue, Cash Flow and Net Income Data
Date (Data in AUD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-06-30 3,280.00 307.80 290.50
2019-03-31 2,955.15 220.50 296.50
2018-12-31 2,630.30 133.20 302.50
2018-09-30 2,747.60 227.85 302.25
2018-06-30 2,864.90 322.50 302.00
2018-03-31 2,996.60 357.00 297.55
2017-12-31 3,128.30 391.50 293.10
2017-09-30 3,034.60 394.55 285.00
2017-06-30 2,940.90 397.60 276.90
2017-03-31 2,490.20 346.25 319.85
2016-12-31 2,039.50 294.90 362.80
2016-09-30 2,038.85 311.30 359.55
2016-06-30 2,038.20 327.70 356.30
2016-03-31 2,017.30 365.45 347.20
2015-12-31 1,996.40 403.20 338.10
2015-09-30 1,950.00 351.10 337.40
2015-06-30 1,903.60 299.00 336.70
2015-03-31 2,093.70 301.70 347.45
2014-12-31 2,283.80 304.40 358.20
2014-09-30 2,190.00 322.50 341.65
2014-06-30 2,096.20 340.60 325.10
2014-03-31 1,768.40 350.85 277.05
2013-12-31 1,440.60 361.10 229.00
2013-09-30 1,582.45 388.95 229.40
2013-06-30 1,724.30 416.80 229.80
2013-03-31 1,776.50 383.65 227.85
2012-12-31 1,828.70 350.50 225.90

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Challenger has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Challenger used its assets less efficiently than the DE Diversified Financial industry average last year based on Return on Assets.
  • Challenger has significantly improved its use of capital last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Challenger's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Diversified Financial industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Challenger has a total score of 1/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Challenger's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Challenger's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Challenger is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Challenger's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of Challenger's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 1.7x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Challenger Company Filings, last reported 3 months ago.

DB:GK9 Past Debt and Equity Data
Date (Data in AUD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-06-30 3,622.80 7,395.20 11,222.30
2019-03-31 3,622.80 7,395.20 11,222.30
2018-12-31 3,403.10 7,122.80 19,336.50
2018-09-30 3,403.10 7,122.80 19,336.50
2018-06-30 3,485.80 6,898.30 8,725.00
2018-03-31 3,485.80 6,898.30 8,725.00
2017-12-31 3,483.60 6,349.40 17,063.90
2017-09-30 3,483.60 6,349.40 17,063.90
2017-06-30 2,901.30 6,658.90 7,287.20
2017-03-31 2,901.30 6,658.90 7,287.20
2016-12-31 2,794.00 6,304.80 14,982.20
2016-09-30 2,794.00 6,304.80 14,982.20
2016-06-30 2,684.00 6,263.60 7,040.00
2016-03-31 2,684.00 6,263.60 7,040.00
2015-12-31 2,784.20 5,525.50 12,345.10
2015-09-30 2,784.20 5,525.50 12,345.10
2015-06-30 2,638.60 5,427.40 6,578.10
2015-03-31 2,638.60 5,427.40 6,578.10
2014-12-31 2,610.10 5,353.80 11,307.40
2014-09-30 2,610.10 5,353.80 11,307.40
2014-06-30 2,276.10 5,426.50 5,884.10
2014-03-31 2,276.10 5,426.50 5,884.10
2013-12-31 2,416.20 5,647.00 10,232.50
2013-09-30 2,416.20 5,647.00 10,232.50
2013-06-30 2,294.20 5,961.20 5,839.30
2013-03-31 2,294.20 5,961.20 5,839.30
2012-12-31 2,140.20 6,223.70 9,258.30
  • Challenger's level of debt (204.1%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has been reduced over the past 5 years (238% vs 204.1% today).
  • Debt is not well covered by operating cash flow (8.8%, less than 20% of total debt).
  • Interest payments on debt are not well covered by earnings (EBIT is 1.9x annual interest expense, ideally 3x coverage).
X
Financial health checks
We assess Challenger's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Challenger has a total score of 2/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Challenger's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
5.17%
Current annual income from Challenger dividends. Estimated to be 5.12% next year.
If you bought €2,000 of Challenger shares you are expected to receive €103 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Challenger's pays a higher dividend yield than the bottom 25% of dividend payers in Germany (1.46%).
  • Challenger's dividend is above the markets top 25% of dividend payers in Germany (3.86%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
DB:GK9 Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 11 Analyst Estimates (S&P Global) See Below
Europe Diversified Financial Industry Average Dividend Yield Market Cap Weighted Average of 32 Stocks 3.2%
Germany Market Average Dividend Yield Market Cap Weighted Average of 337 Stocks 3.1%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.7%
Germany Bottom 25% Dividend Yield 25th Percentile 1.5%
Germany Top 25% Dividend Yield 75th Percentile 3.9%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

DB:GK9 Future Dividends Estimate Data
Date (Data in A$) Dividend per Share (annual) Avg. No. Analysts
2022-06-30 0.35 10.00
2021-06-30 0.35 13.00
2020-06-30 0.36 13.00
2019-10-13
DB:GK9 Past Annualized Dividends Data
Date (Data in A$) Dividend per share (annual) Avg. Yield (%)
2019-08-12 0.355 5.096
2019-02-11 0.355 4.741
2018-08-13 0.360 3.651
2018-02-12 0.350 2.887
2017-08-14 0.350 2.656
2017-02-13 0.340 2.676
2016-08-15 0.330 3.180
2016-03-18 0.320 3.586
2015-08-17 0.310 3.998
2015-02-16 0.290 4.163
2014-08-19 0.270 3.992
2013-08-19 0.200 3.162
2013-02-28 0.200 4.930
2012-08-20 0.170 4.955
2012-02-20 0.170 4.818
2011-08-22 0.165 3.751
2010-08-23 0.145 3.123
2010-02-22 0.135 3.555
2009-08-24 0.125 3.335
2009-02-16 0.125 6.989

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Dividends per share have been stable in the past 10 years.
  • Dividends per share have increased over the past 10 years.
Current Payout to shareholders
What portion of Challenger's earnings are paid to the shareholders as a dividend.
  • Dividends paid are covered by earnings (1.4x coverage).
Future Payout to shareholders
  • Dividends after 3 years are expected to be covered by earnings (1.7x coverage).
X
Income/ dividend checks
We assess Challenger's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.7%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Challenger afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Challenger has a total score of 6/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Challenger's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Richard Howes
COMPENSATION A$3,639,091
TENURE AS CEO 0.8 years
CEO Bio

Mr. Richard J. Howes has been the Managing Director, Director and Chief Executive Officer of Challenger Ltd. since January 02, 2019. Mr. Howes served as the Chief Executive of Distribution, Product and Marketing at Challenger Limited from February 13, 2017 to December 12, 2018. In this role, Mr. Howes was responsible for the overall strategic direction and coordination of the Group's distribution, product, marketing and research functions. Mr. Howes served as the Chief Executive of Challenger Life Company Limited at Challenger Limited until February 13, 2017 and was previously the Principal Executive Officer of CL2. Mr. Howes holds overall executive responsibility for the management of the firm's APRA regulated life company. He joined Challenger in June 2003. He has also previously held the role of Challenger Life's Chief Investment Officer. Previously, Mr. Howes was employed at Zurich Capital Markets where he provided risk management solutions to major companies and institutions globally. Prior to this, he spent seven years within the financial markets divisions at Macquarie and Bankers Trust, where his primary responsibility was providing risk management solutions to major companies and institutions globally. Mr. Howes started his career in the strategy department at Queensland Investment Corporation in 1992, where he was successful in designing and implementing an investment performance attribution system. He is also on the Advisory Board of the University of Queensland Business School. He has a Bachelor of Commerce (hons) in Finance and Accounting and a Bachelor of Economics and has completed the Advanced Management Program at Harvard Business School.

CEO Compensation
  • Richard's compensation has been consistent with company performance over the past year, both up more than 20%.
  • Richard's remuneration is about average for companies of similar size in Germany.
Management Team Tenure

Average tenure of the Challenger management team in years:

7.5
Average Tenure
  • The average tenure for the Challenger management team is over 5 years, this suggests they are a seasoned and experienced team.
Management Team

Richard Howes

TITLE
MD, CEO & Director
COMPENSATION
A$4M
TENURE
0.8 yrs

Andrew Tobin

TITLE
Chief Financial Officer
COMPENSATION
A$2M
TENURE
7.7 yrs

Angela Murphy

TITLE
Chief Executive of Distribution
COMPENSATION
A$964K
TENURE
0.8 yrs

Stuart Kingham

TITLE
Head of Investor Relations
TENURE
7.5 yrs

Michael D. Vardanega

TITLE
Chief Executive of Group Strategy
TENURE
8.6 yrs

Jane Keeley

TITLE
Head of External Communications

Michelle Taylor

TITLE
Chief Executive of People
TENURE
0.8 yrs

Trent Alston

TITLE
Head of Property

Jeremy Cooper

TITLE
Chairman of Retirement Income
TENURE
8.9 yrs

Paul Marriage

TITLE
Acting Head of Corporate Affairs & Advocacy
Board of Directors Tenure

Average tenure and age of the Challenger board of directors in years:

1.8
Average Tenure
62
Average Age
  • The average tenure for the Challenger board of directors is less than 3 years, this suggests a new board.
Board of Directors

Peter Polson

TITLE
Independent Non-Executive Chairman
COMPENSATION
A$526K
AGE
73
TENURE
15.3 yrs

Richard Howes

TITLE
MD, CEO & Director
COMPENSATION
A$4M
TENURE
0.8 yrs

JoAnne Stephenson

TITLE
Independent Non-Executive Director
COMPENSATION
A$266K
TENURE
7 yrs

Steven Gregg

TITLE
Independent Non-Executive Director
COMPENSATION
A$257K
AGE
58
TENURE
7 yrs

Melanie Victoria Willis

TITLE
Independent Non-Executive Director
COMPENSATION
A$230K
AGE
54
TENURE
1.8 yrs

Leon Zwier

TITLE
Independent Non-Executive Director
COMPENSATION
A$179K
TENURE
13.1 yrs

John Green

TITLE
Independent Non-Executive Director
COMPENSATION
A$223K
AGE
66
TENURE
1.8 yrs

Duncan West

TITLE
Independent Non-Executive Director
COMPENSATION
A$147K
TENURE
1.1 yrs

Masahiko Kobayashi

TITLE
Non-Executive Director
TENURE
0.2 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
05. Sep 19 Sell UBS Asset Management Company 29. Aug 19 03. Sep 19 -1,954,222 €4.37 €-8,533,427
05. Sep 19 Buy UBS Asset Management Company 29. Aug 19 03. Sep 19 2,113,189 €4.15 €8,514,225
01. Sep 19 Sell UBS Asset Management Company 14. Aug 19 28. Aug 19 -10,739,355 €4.14 €-43,936,969
01. Sep 19 Buy UBS Asset Management Company 14. Aug 19 28. Aug 19 9,380,503 €4.09 €38,346,467
15. Aug 19 Sell UBS Asset Management Company 15. Apr 19 13. Aug 19 -45,450,200 €5.13 €-195,838,954
15. Aug 19 Buy UBS Asset Management Company 15. Apr 19 13. Aug 19 42,003,428 €4.89 €181,142,888
18. Jun 19 Buy MS&AD Insurance Group Holdings, Inc., Asset Management Arm Company 29. May 19 14. Jun 19 6,962,148 €5.04 €32,039,483
26. May 19 Sell The Vanguard Group, Inc. Company 17. Jan 19 15. May 19 -421,998 €5.77 €-2,426,626
26. May 19 Buy The Vanguard Group, Inc. Company 17. Jan 19 16. May 19 1,966,391 €5.74 €11,269,182
16. Apr 19 Sell UBS Asset Management Company 15. Mar 19 12. Apr 19 -8,880,996 €5.07 €-44,370,899
16. Apr 19 Buy UBS Asset Management Company 15. Mar 19 12. Apr 19 13,065,886 €5.05 €64,781,426
02. Apr 19 Buy MS&AD Insurance Group Holdings, Inc., Asset Management Arm Company 14. Mar 19 29. Mar 19 6,960,000 €5.20 €35,143,307
18. Mar 19 Sell UBS Asset Management Company 25. Feb 19 14. Mar 19 -6,036,205 €5.13 €-30,754,095
18. Mar 19 Buy UBS Asset Management Company 25. Feb 19 14. Mar 19 7,482,965 €5.08 €37,941,326
15. Mar 19 Buy MS&AD Insurance Group Holdings, Inc., Asset Management Arm Company 28. Feb 19 13. Mar 19 6,800,000 €5.29 €34,729,665
28. Feb 19 Buy MS&AD Insurance Group Holdings, Inc., Asset Management Arm Company 19. Feb 19 27. Feb 19 6,700,000 €5.22 €33,030,629
26. Feb 19 Sell UBS Asset Management Company 15. Feb 19 22. Feb 19 -3,656,742 €4.85 €-17,735,362
26. Feb 19 Buy UBS Asset Management Company 15. Feb 19 22. Feb 19 3,426,762 €5.00 €16,771,094
18. Feb 19 Sell UBS Asset Management Company 31. Jan 19 14. Feb 19 -7,784,495 €4.86 €-37,230,572
18. Feb 19 Buy UBS Asset Management Company 31. Jan 19 14. Feb 19 8,176,242 €4.86 €38,929,637
19. Feb 19 Buy MS&AD Insurance Group Holdings, Inc., Asset Management Arm Company 07. Dec 18 18. Feb 19 7,610,000 €6.29 €41,574,278
01. Feb 19 Sell UBS Asset Management Company 11. Jan 19 30. Jan 19 -12,081,937 €5.84 €-61,211,554
01. Feb 19 Buy UBS Asset Management Company 11. Jan 19 30. Jan 19 14,069,739 €5.76 €69,764,575
14. Jan 19 Sell UBS Asset Management Company 04. Jan 19 10. Jan 19 -1,783,912 €5.86 €-10,389,746
14. Jan 19 Buy UBS Asset Management Company 04. Jan 19 10. Jan 19 1,453,695 €5.87 €8,443,563
07. Jan 19 Sell UBS Asset Management Company 01. Jan 19 03. Jan 19 -770,659 €5.66 €-4,359,394
07. Jan 19 Buy UBS Asset Management Company 02. Jan 19 03. Jan 19 687,441 €5.65 €3,877,806
03. Jan 19 Sell UBS Asset Management Company 23. Nov 18 31. Dec 18 -14,810,779 €6.02 €-89,143,618
03. Jan 19 Buy UBS Asset Management Company 23. Nov 18 31. Dec 18 12,047,487 €5.93 €71,385,776
09. Dec 18 Buy MS&AD Insurance Group Holdings, Inc., Asset Management Arm Company 29. Nov 17 06. Dec 18 6,338,602 €8.04 €50,966,913
04. Dec 18 Buy John Green Individual 03. Dec 18 03. Dec 18 10,000 €6.44 €64,413
26. Nov 18 Sell UBS Asset Management Company 01. Nov 18 22. Nov 18 -10,551,133 €6.69 €-70,623,442
26. Nov 18 Buy UBS Asset Management Company 01. Nov 18 22. Nov 18 5,304,493 €6.37 €32,953,248
07. Nov 18 Buy Duncan West Individual 02. Nov 18 02. Nov 18 18,957 €6.67 €126,365
02. Nov 18 Sell UBS Asset Management Company 30. Oct 18 31. Oct 18 -1,397,181 €6.55 €-9,149,050
02. Nov 18 Buy UBS Asset Management Company 30. Oct 18 31. Oct 18 633,765 €6.62 €4,195,708
31. Oct 18 Sell UBS Asset Management Company 15. Oct 18 17. Oct 18 -2,815 €6.64 €-18,680
31. Oct 18 Buy UBS Asset Management Company 17. Oct 18 25. Oct 18 154,132 €7.22 €1,082,168
X
Management checks
We assess Challenger's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Challenger has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Company Info

Description

Challenger Limited is a publicly owned investment manager. The company also provides retirement services to its clients. It manages equity mutual funds. The firm invests into the public equity markets. Challenger Limited was founded in 1985 and is based in Australia, Asia and United Kingdom.

Details
Name: Challenger Limited
GK9
Exchange: DB
Founded: 1985
A$2,562,286,409
606,161,115
Website: http://challenger.com.au
Address: Challenger Limited
5 Martin Place,
Level 2,
Sydney,
New South Wales, 2000,
Australia
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
ASX CGF Ordinary Shares Australian Securities Exchange AU AUD 23. Dec 2003
DB GK9 Ordinary Shares Deutsche Boerse AG DE EUR 23. Dec 2003
CHIA CGF Ordinary Shares Chi-X Australia AU AUD 23. Dec 2003
OTCPK CFIG.Y UNSPONSORD ADR Pink Sheets LLC US USD 04. Nov 2008
Number of employees
Current staff
Staff numbers
687
Challenger employees.
Industry
Other Diversified Financial Services
Diversified Financials
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/10/13 22:34
End of day share price update: 2019/10/11 00:00
Last estimates confirmation: 2019/10/08
Last earnings filing: 2019/08/12
Last earnings reported: 2019/06/30
Last annual earnings reported: 2019/06/30


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.